Pfizer to scale down early-stage rare disease research - Medical Dialogues

Retrieved on: 2023-01-06 10:06:46

Tags for this article:

Click the tags to see associated articles and topics

Pfizer to scale down early-stage rare disease research - Medical Dialogues. View article details on hiswai:

Excerpt

Pfizer said its oncology research portfolio will become even more focused around breast, prostate and hematological cancer franchises.

Article found on: medicaldialogues.in